Inflammaging in Multidrug-Resistant Sepsis of Geriatric ICU Patients and Healthcare Challenges
N. Kumar,
No information about this author
Tejashree A. Balraj,
No information about this author
Kusuma K Shivashankar
No information about this author
et al.
Geriatrics,
Journal Year:
2024,
Volume and Issue:
9(2), P. 45 - 45
Published: April 3, 2024
Multidrug-resistant
sepsis
(MDR)
is
a
pressing
concern
in
intensive
care
unit
(ICU)
settings,
specifically
among
geriatric
patients
who
experience
age-related
immune
system
changes
and
comorbidities.
The
aim
of
this
review
to
explore
the
clinical
impact
MDR
ICU
shed
light
on
healthcare
challenges
associated
with
its
management.
We
conducted
comprehensive
literature
search
using
National
Center
for
Biotechnology
Information
(NCBI)
Google
Scholar
engines.
Our
incorporated
keywords
such
as
"multidrug-resistant
sepsis"
OR
"MDR
sepsis",
"geriatric
patients"
"elderly
patients",
"complications",
"healthcare
burdens",
"diagnostic
challenges",
challenges"
"ICU
"geriatric/elderly
patients".
This
explores
specific
risk
factors
contributing
sepsis,
complexities
diagnostic
challenges,
burden
faced
by
elderly
patients.
Notably,
population
bears
higher
(57.5%),
influenced
various
factors,
including
comorbidities,
immunosuppression,
changes,
resource-limited
settings.
Furthermore,
imposes
significant
economic
systems,
annual
costs
exceeding
$27
billion
USA.
These
findings
underscore
urgency
addressing
need
tailored
interventions
improve
outcomes
reduce
costs.
Language: Английский
Senescence-related Genes as Prognostic Markers for STEMI Patients: LASSO Regression-Based Bioinformatics and External Validation
X.J. Wang,
No information about this author
Lei Huang,
No information about this author
Min Hou
No information about this author
et al.
Journal of Cardiovascular Translational Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
Language: Английский
The interplay of senescence and MMPs in myocardial infarction: implications for cardiac aging and therapeutics
Biogerontology,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Jan. 20, 2025
Language: Английский
Circadian Rhythm, Hypoxia, and Cellular Senescence: From Molecular Mechanisms to Targeted Strategies
Tong Nie,
No information about this author
Eugenie Nepovimová,
No information about this author
Qinghua Wu
No information about this author
et al.
European Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 177290 - 177290
Published: Jan. 1, 2025
Language: Английский
Cellular Senescence and Cardiovascular Aging
Dharmesh Kapoor,
No information about this author
Imteyaz Qamar
No information about this author
Published: Jan. 1, 2025
Cellular senescence and senotherapeutics in cardiovascular diseases
Arttatrana Pal
No information about this author
Advances in pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Analysis of cellular senescence-related genes in calcified aortic valve disease and the potential therapeutic role of β-Carotene
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(3), P. e0318574 - e0318574
Published: March 10, 2025
Objective
Calcific
aortic
valve
disease
(CAVD)
is
a
progressive,
age-related
degenerative
characterized
by
the
accumulation
of
calcium
deposits
in
valve.
We
aim
to
screen
key
genes
associated
with
cellular
senescence
(CS)
CAVD.
Methods
The
GSE12644
and
GSE51472
datasets
from
GEO
database
was
utilized
this
study,
differentially
expressed
(DEGs)
were
identified
using
“
limma
”
R
package.
CS-related
DEGs
(CS-DEGs)
determined
through
CellAge
database.
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment
analyses
performed
on
CS-DEGs.
A
protein–protein
interaction
(PPI)
network
constructed
STRING
cytoHubba
plug-in
Cytoscape
used
identify
hub
genes.
noncoding-RNA-mRNA
regulatory
established.
DSigDB
drugs
potentially
be
useful
for
treating
Results
total
16
CS-DEGs
identified.
These
primarily
collagen
metabolic
process,
catabolic
process
external
side
plasma
membrane.
10
as
regulators
CAVD:
LPAR1,
PTPN6,
CD28,
ID1,
MEIS2,
FGFR3,
KDR,
MMP7,
AR,
HIF1A.
Noncoding
RNA-mRNA
indicated
that
may
regulated
noncoding
RNAs.
β-Carotene,
naturally
occurring
carotenoid
antioxidant
properties,
potential
therapeutic
agents
interacting
MMP9,
CTSB.
Conclusion
This
study
provides
insights
into
pathways
related
CAVD
(MMP9,
CTSB)
highlights
role
β-Carotene
treatment
Language: Английский
The potential of flavonoids to mitigate cellular senescence in cardiovascular disease
Huimin Zheng,
No information about this author
Tiantian Li,
No information about this author
Ziyun Hu
No information about this author
et al.
Biogerontology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 26, 2024
Language: Английский
The role of senescence in cancer therapy-associated cardiovascular toxicity
Yasmin K. Alshoubaki,
No information about this author
Vivienne Grüterich,
No information about this author
Valentina Zollet
No information about this author
et al.
The Journal of Cardiovascular Aging,
Journal Year:
2024,
Volume and Issue:
4(4)
Published: Nov. 19, 2024
Cardiovascular
diseases
(CVDs)
and
cancer
are
the
two
leading
causes
of
global
mortality.
Cancer
treatments,
including
radiotherapy
chemotherapy,
can
have
severe
cardiotoxic
side
effects,
raising
concerns
for
patients
increasing
financial
burden
on
healthcare
systems.
Recent
studies
shown
a
link
between
therapy-induced
cardiotoxicity
cardiac
senescence.
Specifically,
systemic
therapies
known
to
induce
senescence,
which
may
directly
result
in
dysfunction
or
enhance
vulnerability
heart
other
stressors.
Besides
anthracyclines,
newer,
more
targeted
such
as
tyrosine
kinase
inhibitors
(TKIs)
also
been
Cellular
senescence
is
triggered
by
DNA
damage,
oncogene
activation,
reactive
oxygen
nitrogen
species,
stressors,
secretion
proinflammatory
factors,
increased
oxidative
stress,
disruption
normal
cellular
functions.
Understanding
molecular
mechanisms
induced
therapy
essential
attenuating
even
preventing
clinically
overt
using
senotherapies
senolytics
senomorphics.
In
this
review,
that
associated
with
CVDs
described
an
emphasis
potential
role
disease
progression.
addition,
particularly
doxorubicin
(DOX),
radiotherapy,
TKIs
lead
highlighted.
Finally,
recent
novel
treating
discussed
focus
targeting
following
treatment.
The
field
remains
its
early
stages,
further
research
required
clarify
how
treatments
contribute
cardiotoxicity.
At
same
time,
identifying
be
safely
combined
drugs
protecting
health
patients.
Language: Английский
Platelet amino acid spectrum and gut microbiota, their links in patients with coronary artery disease and atrial fibrillation
I.O. Melnychuk,
No information about this author
M.L. Sharayeva,
No information about this author
V.N. Kramarova
No information about this author
et al.
GASTROENTEROLOGY,
Journal Year:
2023,
Volume and Issue:
57(4), P. 227 - 233
Published: Dec. 22, 2023
Background.
The
aim
of
our
work
was
to
identify
the
links
between
platelet
amino
acid
(AA)
spectrum
and
gut
microbiota
composition
in
patients
with
coronary
artery
disease
(CAD)
atrial
fibrillation
(AF)
evaluate
them.
Materials
methods.
Three
hundred
were
enrolled
study.
They
divided
into
3
groups:
I
—
149
CAD
but
without
arrhythmias,
II
(CAD
+
AF)
124
people
AF
paroxysm,
control
group
(CG)
27
individuals
arrhythmias.
Platelet
AA
level
assessed
by
method
ion-exchange
liquid
column
chromatography.
Gut
studied
16-S
rRNA
sequencing.
Results.
A
significant
increase
isoleucine
(10.73
%),
leucine
(12.63
%)
a
decrease
threonine
(23.05
serine
(5.06
glycine
(32.21
valine
(30.83
platelets
levels
found
(P
<
0.05).
In
addition,
they
had
Bacteroides
spp.,
Faecalibacterium
prausnitzii,
Actinobacter
Streptococcus
Ruminococcus
spp.
Lactobacillus
Bifidobacterium
Eubacterium
rectale
glutamine
acid,
valine,
glycine,
asparagine
highest
number
correlations
species
Blautia
Akkermansia
muciniphila
Roseburia
inulinivorans
acids
Conclusions.
are
closely
linked.
Language: Английский